Sector
PharmaceuticalsOpen
₹722Prev. Close
₹726Turnover(Lac.)
₹3,616.98Day's High
₹743.2Day's Low
₹72252 Week's High
₹84252 Week's Low
₹368Book Value
₹124.66Face Value
₹2Mkt Cap (₹ Cr.)
5,917.9P/E
31.5EPS
23.35Divi. Yield
0.14Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 16.1 | 16.1 | 16.1 | 14.64 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 799.27 | 683.36 | 599.59 | 253.95 |
Net Worth | 815.37 | 699.46 | 615.69 | 268.59 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 |
---|---|
Revenue | 385.36 |
yoy growth (%) | |
Raw materials | -128.12 |
As % of sales | 33.24 |
Employee costs | -32.76 |
Y/e 31 Mar( In .Cr) | Mar-2021 |
---|---|
Profit before tax | 167.31 |
Depreciation | -6.76 |
Tax paid | -43.71 |
Working capital | |
Other operating items |
Y/e 31 Mar | Mar-2021 |
---|---|
Growth matrix (%) | |
Revenue growth | |
Op profit growth | |
EBIT growth | |
Net profit growth |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,679.7 | 94.05 | 4,02,788.36 | 2,000.46 | 0.95 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,876 | 82.52 | 1,82,282.67 | 667 | 0.44 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,508.7 | 25.32 | 1,21,846.76 | 1,485.4 | 1.06 | 4,254.47 | 397.41 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,334.1 | 59.26 | 1,12,908.79 | 474 | 0.96 | 2,385 | 224.33 |
Dr Reddys Laboratories Ltd DRREDDY | 1,291.3 | 20.06 | 1,07,932.29 | 1,200.7 | 0.62 | 5,546.3 | 345.76 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Executive Chairman & WTD
Satish Waman Wagh
Whole-time Director
Smita Satish Wagh
Whole-time Director
Soloni Satish Wagh
Joint Managing Director
Shivani Satish Wagh
Whole-time Director
Balasahab Gulabrao Sawant
Independent Director
Dileep Kumar Jain
Independent Director
Dinesh N Modi
Independent Director
Neelam Yashpal Arora
Whole-time Director
Manoj Deo Dorlikar
Independent Director
Ganapati D Yadav
Independent Director
Sunil Subhash Bhagwat
Company Sec. & Compli. Officer
Prachi Sathe
207/208 Udyog Bhavan,
Sonawala Road Goregaon (East),
Maharashtra - 400063
Tel: 91-22-40332727
Website: http://www.supriyalifescience.com
Email: cs@supriyalifescience.com
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: www.linkintime.co.in
Email: paytm.ipo@linkintime.co.in
Summary
Supriya Lifescience Limited was initially constituted on October 29, 1985, as a Partnership Firm under the name M/s Supriya Chemicals. The Partnership Firm was last re-constituted pursuant to a Partne...
Read More
Reports by Supriya Lifescience Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.